These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10389607)

  • 41. The economic costs associated with physical inactivity and obesity in Canada: an update.
    Katzmarzyk PT; Janssen I
    Can J Appl Physiol; 2004 Feb; 29(1):90-115. PubMed ID: 15001807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using administrative data to analyze the prevalence and distribution of schizophrenic disorders.
    Goldner EM; Jones W; Waraich P
    Psychiatr Serv; 2003 Jul; 54(7):1017-21. PubMed ID: 12851440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The economic burden of end-stage renal disease in Canada.
    Zelmer JL
    Kidney Int; 2007 Nov; 72(9):1122-9. PubMed ID: 17700643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The costs of schizophrenia. Assessing the burden.
    Rupp A; Keith SJ
    Psychiatr Clin North Am; 1993 Jun; 16(2):413-23. PubMed ID: 8332569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The economic burden of schizophrenia in Germany: a population-based retrospective cohort study using genetic matching.
    Frey S
    Eur Psychiatry; 2014 Oct; 29(8):479-89. PubMed ID: 24853296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishing a cost estimation model for hypertension and its related diseases in Taiwan.
    Yang MC; Huang IC
    J Formos Med Assoc; 1999 Jun; 98(6):394-402. PubMed ID: 10443062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council.
    Am J Psychiatry; 1993 Oct; 150(10):1447-65. PubMed ID: 8379547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988.
    Rice DP; Kelman S; Miller LS
    Public Health Rep; 1991; 106(3):280-92. PubMed ID: 1905049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
    Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic burden of excessive sedentary behaviour in Canada.
    Chaput JP; Janssen I; Lang JJ; Sampasa-Kanyinga H
    Can J Public Health; 2023 Apr; 114(2):165-174. PubMed ID: 36696033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence, Employment Rate, and Cost of Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using Comprehensive Health and Welfare Registers.
    Evensen S; Wisløff T; Lystad JU; Bull H; Ueland T; Falkum E
    Schizophr Bull; 2016 Mar; 42(2):476-83. PubMed ID: 26433216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Disability Pension and Productivity Loss in Schizophrenia - An Empirical Analysis of the Financial Burden in Germany].
    Kortmann LM; Müller D; Simic D; Civello D; Stock S
    Psychiatr Prax; 2017 Mar; 44(2):93-98. PubMed ID: 27399592
    [No Abstract]   [Full Text] [Related]  

  • 59. The economic burden of smoking in California.
    Max W; Rice DP; Sung HY; Zhang X; Miller L
    Tob Control; 2004 Sep; 13(3):264-7. PubMed ID: 15333882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Needs of schizophrenic's patients in perspective economical consequences of incapacity for work].
    Maciag A
    Przegl Epidemiol; 2007; 61(3):601-6. PubMed ID: 18069399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.